Thermo Fisher Scientific Inc. (TMO)

557.80 +3.48 (+0.63%) As of 10:04AM EDT. Market open.

Thermo Fisher Scientific Inc.

168 Third Avenue
Waltham, MA 02451
United States
781 622 1000
https://www.thermofisher.com

Sector(s): Healthcare
Industry: Diagnostics & Research
Full Time Employees: 130,000

Key Executives

Name	Title	Pay	Exercised	Year Born
Mr. Marc N. Casper	Chairman, Pres & CEO	8.68M	N/A	1968
Mr. Stephen Williamson	Sr. VP & CFO	3.15M	11.46M	1967
Mr. Michel Lagarde	Exec. VP & COO	3.25M	14.12M	1975
Mr. Gianluca Pettiti	Exec. VP	1.61M	2.2M	1979
Mr. Joseph R. Holmes	VP & Chief Accounting Officer	N/A	N/A	1980
Mr. Ryan J. Snyder	Sr. VP & Chief Information Officer	N/A	N/A	N/A
Dr. Karen E. Nelson Ph.D.	Chief Scientific Officer & Member of Scientific Advisory Board	N/A	N/A	N/A
Mr. Rafael Tejada	VP of Investor Relations	N/A	N/A	N/A
Mr. Michael A. Boxer Esq.	Sr. VP, Gen. Counsel & Sec.	N/A	N/A	1962
Ms. Sandy B. Pound	VP & Chief Communications Officer	N/A	N/A	N/A

Amounts are as of December 31, 2021 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the United States and internationally. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases; and solutions include biosciences, genetic sciences, clinical next-generation sequencing, bio production to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for use in laboratory, on production line, and in field for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, and calibration verification fluids; immunodiagnostics develops, manufactures and markets complete bloodtest systems to support the clinical diagnosis and monitoring of allergy, asthma and autoimmune diseases; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Biopharma Services segment provides laboratory products, laboratory chemicals, research and safety market channel, and pharma services and clinical research. The company offers products and services through a direct sales force, customer-service professionals, electronic commerce, third-party distributors, and catalogs. Thermo Fisher Scientific Inc. was founded in 1956 and is headquartered in Waltham, Massachusetts.

Corporate Governance

Thermo Fisher Scientific Inc.’s ISS Governance QualityScore as of March 1, 2023 is 4. The pillar scores are Audit: 5; Board: 5; Shareholder Rights: 4; Compensation: 4.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.